Benvenue Medical has announced it completed a $64 million round of financing.
Benvenue Medical, headquartered in Santa Clara, Calif., is a developer of minimally invasive solutions for spine repair.
The financing is a combination of $40 million in series E equity supplemented with $24 million in debt. The series E equity financing was led by new investor InterWest Partners with all existing major investors participating.
Benvenue indicated it intends to use the funds to build its U.S. commercial presence, scale up manufacturing, increase administrative functions to support overall corporate growth and provide working capital to fund growth in operating activities.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
